P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Kaufman, DR
- Beteiligte Personen und Organisationen
-
Simmons, NL
Barouch, DH
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P148
- URN
-
urn:nbn:de:1111-2016080711798
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaufman, DR
- Simmons, NL
- Barouch, DH
- SpringerLink (Online service)
Ähnliche Objekte (12)
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+cytotoxic T lymphocytes
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
Hepatic stellate cells induce gut tropism of CD8+ T lymphocytes
Regulatory role of CD8+T lymphocytes in bone marrow eosinophilopoiesis
CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis
TIPE polarity proteins are required for mucosal deployment of T lymphocytes and mucosal defense against bacterial infection
Optimization of the immune responses elicited following delivery of vaccine antigens by the mucosal route
Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
Deciphering the complexities of mucosal innate lymphocytes: guardians and potential therapeutic targets
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+cytotoxic T lymphocytes
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
Hepatic stellate cells induce gut tropism of CD8+ T lymphocytes
Regulatory role of CD8+T lymphocytes in bone marrow eosinophilopoiesis
CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis
TIPE polarity proteins are required for mucosal deployment of T lymphocytes and mucosal defense against bacterial infection
Optimization of the immune responses elicited following delivery of vaccine antigens by the mucosal route
Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
Deciphering the complexities of mucosal innate lymphocytes: guardians and potential therapeutic targets
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+cytotoxic T lymphocytes
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
Hepatic stellate cells induce gut tropism of CD8+ T lymphocytes
Regulatory role of CD8+T lymphocytes in bone marrow eosinophilopoiesis
CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis
TIPE polarity proteins are required for mucosal deployment of T lymphocytes and mucosal defense against bacterial infection
Optimization of the immune responses elicited following delivery of vaccine antigens by the mucosal route
Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma